Camilla Thellenberg‐Karlsson

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 871 citations

Medicine, Radiation Oncology, Urology +16

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Per Fransson, Per Nilsson, Adalsteinn Gunnlaugsson et al. · The Lancet Oncology · 2021 · 157 citations

Medicine, Oncology, Radiation Oncology +17

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Silke Gillessen, Fabio Turco, Ian D. Davis et al. · European Urology · 2024 · 115 citations · Full text

Medicine, Oncology, Urology +9

Second Primary Cancers in Men With Prostate Cancer: An Increased Risk of Male Breast Cancer

Camilla Thellenberg‐Karlsson, Beatrice Malmer, Björn Tavelin et al. · The Journal of Urology · 2003 · 90 citations

Medicine, Oncology, Urology +17

Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer

Maria Hedelin, Katarina Bälter, Ellen T. Chang et al. · The Prostate · 2006 · 89 citations · Full text

Public Health, Genetics, Oncology +15